Pro Health Tips
Monday 30 March 2020
Alirocumab Significantly Downs Cholesterol in HoFH Patients
PCSK9 inhibitor named Alirocumab is evaluated for treating patients with homozygous familial hypercholesterolemia (HoFH).
from Medindia Health News https://ift.tt/2JpN83l
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
PCSK9 inhibitor named Alirocumab is evaluated for treating patients with homozygous familial hypercholesterolemia (HoFH).
No comments:
Post a Comment